Comment
CEI Comments on Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program
Comments of the Competitive Enterprise Institute Dear Dr. Oz, The Competitive Enterprise Institute (CEI) submits these comments in support of several provisions…
Comment
CEI Comments on Global Benchmark for Efficient Drug Pricing (GLOBE) Model
Comments of the Competitive Enterprise Institute Dear Dr. Oz, The Competitive Enterprise Institute (CEI) submits these comments in opposition to the creation…
Comment
CEI Comments on Section 232 National Security Investigation of Imports of Personal Protective Equipment, Medical Consumables, and Medical Equipment, Including Devices
Comments of the Competitive Enterprise Institute Dear Deputy Assistant Secretary Khersonsky, The Competitive Enterprise Institute (CEI) submits these comments in opposition to…
Comment
CEI Comments on Use of Orally Ingestible Unapproved Prescription Drug Products Containing Fluoride in the Pediatric Population
Dear Commissioner Makary, The Competitive Enterprise Institute (CEI) submits these comments in favor of the private use of fluoride supplements for children. CEI…